Lupin Diagnostics, a division of global pharmaceutical company Lupin Limited (Lupin), has opened its Reference Laboratory in Guwahati, North East India. The expansion is part of Lupin Diagnostics’ overall plan to extend its footprint in India and provide access to high-quality testing.
In the domains of molecular diagnostics, cytogenetics, flow cytometry, histopathology, cytology, microbiology, serology, haematology, immunology, and routine biochemistry, the Reference Laboratory in Guwahati has the ability to perform a wide range of standard and specialty tests.
“Doctors and patients rely on diagnostic test findings to make educated decisions,” said Ravindra Kumar, Vice President and Head of Lupin Diagnostics. “Accurate diagnosis is the first step toward managing illnesses and selecting effective lines of therapy.”
